	1 2 3 4 5 6 7 8
Crystal Growth and Design	Crystal Growth and Design, 8, 44.44% Crystal Growth and Design 8 publications, 44.44%
CrystEngComm	CrystEngComm, 5, 27.78% CrystEngComm 5 publications, 27.78%
Pharmaceutical Research	Pharmaceutical Research, 1, 5.56% Pharmaceutical Research 1 publication, 5.56%
Physical Chemistry Chemical Physics	Physical Chemistry Chemical Physics, 1, 5.56% Physical Chemistry Chemical Physics 1 publication, 5.56%
European Journal of Pharmaceutical Sciences	European Journal of Pharmaceutical Sciences, 1, 5.56% European Journal of Pharmaceutical Sciences 1 publication, 5.56%
Crystals	Crystals, 1, 5.56% Crystals 1 publication, 5.56%
Journal of Molecular Liquids	Journal of Molecular Liquids, 1, 5.56% Journal of Molecular Liquids 1 publication, 5.56%
	1 2 3 4 5 6 7 8

Publishers

	1 2 3 4 5 6 7 8
American Chemical Society (ACS)	American Chemical Society (ACS), 8, 44.44% American Chemical Society (ACS) 8 publications, 44.44%
Royal Society of Chemistry (RSC)	Royal Society of Chemistry (RSC), 6, 33.33% Royal Society of Chemistry (RSC) 6 publications, 33.33%
Elsevier	Elsevier, 2, 11.11% Elsevier 2 publications, 11.11%
Springer Nature	Springer Nature, 1, 5.56% Springer Nature 1 publication, 5.56%
MDPI	MDPI, 1, 5.56% MDPI 1 publication, 5.56%
	1 2 3 4 5 6 7 8

We do not take into account publications without a DOI.
Statistics recalculated weekly.

Are you a researcher?

Create a profile to get free access to personal recommendations for colleagues and new articles.

Metrics

Cite this

GOST |

Cite this

GOST Copy

Perlovich G. Two-Component Molecular Crystals: What Is the Difference between Drug–Drug, Drug–GRAS, and CF–CF Databases? Evaluation of Melting Points and Ideal Solubility of Unknown Co-crystals // Crystal Growth and Design. 2021. Vol. 21. No. 9. pp. 5058-5071.

GOST all authors (up to 50) Copy

RIS |

Cite this

RIS Copy

TY - JOUR

DO - 10.1021/acs.cgd.1c00477

UR - https://doi.org/10.1021/acs.cgd.1c00477

TI - Two-Component Molecular Crystals: What Is the Difference between Drug–Drug, Drug–GRAS, and CF–CF Databases? Evaluation of Melting Points and Ideal Solubility of Unknown Co-crystals

T2 - Crystal Growth and Design

AU - Perlovich, German

PY - 2021

DA - 2021/07/26

PB - American Chemical Society (ACS)

SP - 5058-5071

IS - 9

VL - 21

SN - 1528-7483

SN - 1528-7505

ER -

BibTex |

Cite this

BibTex (up to 50 authors) Copy

@article{2021_Perlovich,

author = {German Perlovich},

title = {Two-Component Molecular Crystals: What Is the Difference between Drug–Drug, Drug–GRAS, and CF–CF Databases? Evaluation of Melting Points and Ideal Solubility of Unknown Co-crystals},

journal = {Crystal Growth and Design},

year = {2021},

volume = {21},

publisher = {American Chemical Society (ACS)},

month = {jul},

url = {https://doi.org/10.1021/acs.cgd.1c00477},

number = {9},

pages = {5058--5071},

doi = {10.1021/acs.cgd.1c00477}

}

MLA

Cite this

MLA Copy

Perlovich, German. “Two-Component Molecular Crystals: What Is the Difference between Drug–Drug, Drug–GRAS, and CF–CF Databases? Evaluation of Melting Points and Ideal Solubility of Unknown Co-crystals.” Crystal Growth and Design, vol. 21, no. 9, Jul. 2021, pp. 5058-5071. https://doi.org/10.1021/acs.cgd.1c00477.

Publisher

American Chemical Society (ACS)

Journal

Crystal Growth and Design

scimago Q2

wos Q1

SJR

0.633

CiteScore

5.6

Impact factor

3.4

ISSN

15287483 (Print)

15287505 (Electronic)

Profiles

German L Perlovich